SFM
IQMDU

Spartan Fund Management’s Intelligent Medicine Acquisition Corp. Unit IQMDU Stock Holding History

Spartan Fund Management’s Portfolio IQMDU Stock Details IQMDU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-100,000
Closed -$1M – 500
2022
Q2 		$1M Hold
100,000
– – 0.21% 190
2022
Q1 		$1.26M Buy
+100,000
New +$1.01M 0.21% 194

Other funds holding IQMDU

Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $507M AUM 6.15% 1-Year Est. Return
CCA
Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
DCM
Difesa Capital Management New York $38.1M AUM 39.86% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return
WC
Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Spartan Fund Management's IQMDU Position: Q3 2022 in Review

Spartan Fund Management sold out of Intelligent Medicine Acquisition Corp. Unit (IQMDU) in Q3 2022, closing a stake of 100,000 shares — an estimated $1M sold.

Spartan Fund Management first reported a position in IQMDU in Q1 2022 and held it in 2 quarters. The position peaked at $1.26M in Q1 2022. 20 funds tracked by Wall St. Rank hold IQMDU as of Q3 2022.

  • Spartan Fund Management reported no remaining Intelligent Medicine Acquisition Corp. Unit position as of Q3 2022 after selling out during the quarter.
  • Spartan Fund Management sold 100,000 Intelligent Medicine Acquisition Corp. Unit shares in Q3 2022, an estimated $1M.
  • Spartan Fund Management first reported a position in Intelligent Medicine Acquisition Corp. Unit in Q1 2022 and held it in 2 quarters.
  • Spartan Fund Management's Intelligent Medicine Acquisition Corp. Unit position peaked at $1.26M in Q1 2022.
  • 20 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Unit as of Q3 2022.

Based on Spartan Fund Management's 13F filing for Q3 2022, filed 26 Oct 2022.